1. Home
  2. IRIX vs RLYB Comparison

IRIX vs RLYB Comparison

Compare IRIX & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IRIDEX Corporation

IRIX

IRIDEX Corporation

N/A

Current Price

$0.92

Market Cap

20.2M

Sector

Health Care

ML Signal

N/A

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$0.65

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRIX
RLYB
Founded
1989
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.2M
24.1M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
IRIX
RLYB
Price
$0.92
$0.65
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
105.3K
192.7K
Earning Date
11-11-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,647,000.00
$674,000.00
Revenue This Year
$9.61
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.58
12.71
52 Week Low
$0.78
$0.22
52 Week High
$1.95
$1.24

Technical Indicators

Market Signals
Indicator
IRIX
RLYB
Relative Strength Index (RSI) 40.71 55.30
Support Level $0.90 $0.64
Resistance Level $0.97 $0.68
Average True Range (ATR) 0.06 0.04
MACD 0.00 -0.00
Stochastic Oscillator 25.58 48.70

Price Performance

Historical Comparison
IRIX
RLYB

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: